glp 1 agonist trials Mapping the effectiveness and risks of GLP-1 receptor agonists Clinical Outcomes with GLP-1 Receptor

Chronic inflammation can suppress immune function and lead to various health issues

Effect of pembrolizumab plus neoadjuvant chemotherapy on pathologic complete response in women with early-stage breast cancer: an analysis of the ongoing phase 2 adaptively randomized I-SPY2 trial

Serious adverse events occurred in 2.8% of participants in the SURPASS-2 study, which is less frequent than the 5.37% reported among tirzepatide users

Female genital schistosomiasis is a common complication, occurring in approximately 40 million girls and women, making it one of the most common gynecologic conditions in Africa, and schistosome infections have been implicated as cofactors in the acquisition and transmission of HIV and are a WHO-recognized risk factor for HIV infection 4,5

Bulk transcriptomics/proteomics are efficient for cohort-scale signatures and assay development

More info about IV treatments shows how we tailor these powerful formulations to work with your unique needs